Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Thoracic 1Plasma cell 1Lymphoid 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 1364Lung Neoplasms 697Small Cell Lung Carcinoma 202Neoplasms 151Neoplasm Metastasis 130Breast Neoplasms 116Melanoma 99Colorectal Neoplasms 84Adenocarcinoma of Lung 84Ovarian Neoplasms 78Pancreatic Neoplasms 72Carcinoma, Renal Cell 69Head and Neck Neoplasms 66Mesothelioma 58Prostatic Neoplasms 53Urinary Bladder Neoplasms 52Mesothelioma, Malignant 51Stomach Neoplasms 47Triple Negative Breast Neoplasms 45Carcinoma 45Esophageal Neoplasms 43Brain Neoplasms 42Squamous Cell Carcinoma of Head and Neck 41Colonic Neoplasms 35Sarcoma 34Adenocarcinoma, Bronchiolo-Alveolar 33Recurrence 32Adenocarcinoma 31Uterine Cervical Neoplasms 30Parkinson Disease 4, Autosomal Dominant Lewy Body 29

Interventions

Denosumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Humoral Hypercalcemia Of Malignancy × Thoracic × Clear all
NCT00896454 2018-10-17

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Amgen

Phase 2 Completed
33 enrolled 22 charts
BreastGastrointestinalGenitourinaryHead & NeckLymphoidPlasma cellThoracic

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Endocrine Gland Neoplasms, Head and Neck Neoplasms, Hodgkin Disease, Hypercalcemia, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Parathyroid Neoplasms, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡